Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 24 January

Bell Direct
January 24, 2025

Morning Bell 23 January

Bell Direct
January 23, 2025

Morning Bell 22 January

Bell Direct
January 22, 2025

Morning Bell 21 January

Bell Direct
January 21, 2025

Morning Bell 20 January

Bell Direct
January 20, 2025

Weekly Wrap 17 January

Bell Direct
January 17, 2025

Morning Bell 16 January

Bell Direct
January 16, 2025

Morning Bell 15 January

Bell Direct
January 15, 2025

Morning Bell 14 January

Bell Direct
January 14, 2025

Morning Bell 13 January

Bell Direct
January 13, 2025

Weekly Wrap 10 January

Bell Direct
January 10, 2025